178 related articles for article (PubMed ID: 27764777)
41. Prognostic significance of the red blood cell distribution width in diffuse large B-cell lymphoma patients.
Zhou S; Fang F; Chen H; Zhang W; Chen Y; Shi Y; Zheng Z; Ma Y; Tang L; Feng J; Zhang Y; Sun L; Chen Y; Liang B; Yu K; Jiang S
Oncotarget; 2017 Jun; 8(25):40724-40731. PubMed ID: 28388534
[TBL] [Abstract][Full Text] [Related]
42. Are changes in patient-reported outcomes prognostic for diffuse large B-Cell lymphoma survival? Results from the GOYA trial.
Yan JT; Bel C; Trask PC; Lo E
J Patient Rep Outcomes; 2024 Mar; 8(1):31. PubMed ID: 38498084
[TBL] [Abstract][Full Text] [Related]
43. Peripheral blood T cell alterations in newly diagnosed diffuse large B cell lymphoma patients and their long-term dynamics upon rituximab-based chemoimmunotherapy.
Battella S; Cox MC; La Scaleia R; Di Napoli A; Di Landro F; Porzia A; Franchitti L; Mainiero F; Ruco L; Monarca B; Santoni A; Palmieri G
Cancer Immunol Immunother; 2017 Oct; 66(10):1295-1306. PubMed ID: 28555258
[TBL] [Abstract][Full Text] [Related]
44. The impact of marginalization on diffuse large B-cell lymphoma overall survival: a retrospective cohort study.
Arya S; Mozessohn L; Gong I; Faught N; Liu N; Singh S; Chan K; Cheung MC
Leuk Lymphoma; 2024 May; 65(5):629-637. PubMed ID: 38265355
[TBL] [Abstract][Full Text] [Related]
45. Epiregulin: A new prognostic molecule in non-Hodgkin lymphoma.
Demir I; Akan OY; Bilgir F; Yilmaz I; Bozkaya G; Bilgir O
Ir J Med Sci; 2024 Jun; 193(3):1201-1207. PubMed ID: 38270775
[TBL] [Abstract][Full Text] [Related]
46. Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment era.
Tao L; Clarke CA; Rosenberg AS; Advani RH; Jonas BA; Flowers CR; Keegan THM
Br J Haematol; 2017 Jul; 178(1):72-80. PubMed ID: 28542862
[TBL] [Abstract][Full Text] [Related]
47. Survival after diffuse large B-cell lymphoma among children, adolescents, and young adults in California, 2001-2014: A population-based study.
Abrahão R; Ribeiro RC; Lichtensztajn DY; Rosenberg AS; Keegan THM
Pediatr Blood Cancer; 2019 Apr; 66(4):e27559. PubMed ID: 30511461
[TBL] [Abstract][Full Text] [Related]
48. Prognostic value of red blood cell distribution width and D-Dimer in diffuse large B-cell lymphoma: Systematic review and meta-analysis.
Rahchamani M; Sedghi M; Hakimi A; Nejatianfar M; Javaheri T; Tavakoli R; Ahmadi R; Makarem M; Azmi-Naei N; Zahmatkesh Sangani S; Kamandi N; Soleimanian A; Shavaleh R; Foogerdi M; Rahmani K
Cancer Rep (Hoboken); 2024 Jan; 7(1):e1936. PubMed ID: 37997648
[TBL] [Abstract][Full Text] [Related]
49. Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes.
Noerenberg D; Briest F; Hennch C; Yoshida K; Hablesreiter R; Takeuchi Y; Ueno H; Staiger AM; Ziepert M; Asmar F; Locher BN; Toth E; Weber T; Amini RM; Klapper W; Bouzani M; Poeschel V; Rosenwald A; Held G; Campo E; Ishaque N; Stamatopoulos K; Kanellis G; Anagnostopoulos I; Bullinger L; Goldschmidt N; Zinzani PL; Bödör C; Rosenquist R; Vassilakopoulos TP; Ott G; Ogawa S; Damm F
J Clin Oncol; 2024 Feb; 42(4):452-466. PubMed ID: 38055913
[TBL] [Abstract][Full Text] [Related]
50. Prognostic significance of serum monoclonal proteins based on immunofixation electrophoresis in B-cell non-Hodgkin lymphoma.
Gao Y; Feng X; Song W; Li Z; Zhao Z; Zhang J; Zhang L; Zhang M
Ann Hematol; 2024 Apr; 103(4):1261-1271. PubMed ID: 38114824
[TBL] [Abstract][Full Text] [Related]
51. Impact on survival through consolidation radiotherapy for diffuse large B-cell lymphoma: a comprehensive meta-analysis.
Berger MD; Trelle S; Büchi AE; Jegerlehner S; Ionescu C; Lamy de la Chapelle T; Novak U
Haematologica; 2021 Jul; 106(7):1923-1931. PubMed ID: 32554560
[TBL] [Abstract][Full Text] [Related]
52. Overexpression of DNA methyltransferase 1 as a negative independent prognostic factor in primary gastrointestinal diffuse large B-cell lymphoma treated with CHOP-like regimen and rituximab.
Zhao H; Zhang LE; Guo S; Yuan T; Xia B; Zhang L; Zhang Y
Oncol Lett; 2015 May; 9(5):2307-2312. PubMed ID: 26137062
[TBL] [Abstract][Full Text] [Related]
53. Impaired Immune Health in Survivors of Diffuse Large B-Cell Lymphoma.
Shree T; Li Q; Glaser SL; Brunson A; Maecker HT; Haile RW; Levy R; Keegan THM
J Clin Oncol; 2020 May; 38(15):1664-1675. PubMed ID: 32083991
[TBL] [Abstract][Full Text] [Related]
54. Real-world applicability of the International Metabolic Prognostic Index in DLBCL: a validation cohort study.
Ikeda D; Oura M; Uehara A; Tabata R; Narita K; Takeuchi M; Machida Y; Matsue K
Blood Adv; 2024 Apr; 8(8):1893-1897. PubMed ID: 38359408
[No Abstract] [Full Text] [Related]
55. Efficacy and toxicity of the combination chemotherapy of thalidomide, alkylating agent, and steroid for relapsed/refractory myeloma patients: a report from the Korean Multiple Myeloma Working Party (KMMWP) retrospective study.
Kwon J; Min CK; Kim K; Han JJ; Moon JH; Kang HJ; Eom HS; Kim MK; Kim HJ; Yoon DH; Lee JO; Lee WS; Lee JH; Lee JJ; Choi YS; Kim SH; Yoon SS
Cancer Med; 2017 Jan; 6(1):100-108. PubMed ID: 27905203
[TBL] [Abstract][Full Text] [Related]
56. The clinical significance and prognostic value of serum beta-2 microglobulin in adult lymphoma-associated hemophagocytic lymphohistiocytosis: a multicenter analysis of 326 patients.
Jin Z; Miao Y; Zhang J; Zhang J; Wang C; Lu X; Miao Y; Sun M; Zhang Y; Zhuang Y; Ni H; Xu J; Zhuang W; Zhao M; Zhu J; Xu M; Lin G; Hua H; Xie X; Xu M; Jia T; Zhai L; Gu W; Shan Q; Wang Z; Shen Q; Zhang X; Li J; Shi W
Ann Hematol; 2024 Jan; ():. PubMed ID: 38270644
[TBL] [Abstract][Full Text] [Related]
57. Prognostic Impact of Serum β
Vassilakopoulos TP; Arapaki M; Diamantopoulos PT; Liaskas A; Panitsas F; Siakantaris MP; Dimou M; Kokoris SI; Sachanas S; Belia M; Chatzidimitriou C; Konstantinou EA; Asimakopoulos JV; Petevi K; Boutsikas G; Kanellopoulos A; Piperidou A; Lefaki ME; Georgopoulou A; Kopsaftopoulou A; Zerzi K; Drandakis I; Dimopoulou MN; Kyrtsonis MC; Tsaftaridis P; Plata E; Variamis E; Tsourouflis G; Kontopidou FN; Konstantopoulos K; Pangalis GA; Panayiotidis P; Angelopoulou MK
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254729
[TBL] [Abstract][Full Text] [Related]
58. Baseline
Jing F; Liu Y; Zhao X; Wang N; Dai M; Chen X; Zhang Z; Zhang J; Wang J; Wang Y
EJNMMI Res; 2023 Oct; 13(1):92. PubMed ID: 37884763
[TBL] [Abstract][Full Text] [Related]
59. Development and validation of nomogram prognostic model for predicting OS in patients with diffuse large B-cell lymphoma: a cohort study in China.
Li X; Xu Q; Gao C; Yang Z; Li J; Sun A; Wang Y; Lei H
Ann Hematol; 2023 Dec; 102(12):3465-3475. PubMed ID: 37615680
[TBL] [Abstract][Full Text] [Related]
60. Virus Infections Play Crucial Roles in the Pathogenesis of Sjögren's Syndrome.
Otsuka K; Sato M; Tsunematsu T; Ishimaru N
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
